Rezension:

On another call cyclophosphamide cytoxan price The green light from the European Medicines Agency (EMA)paves the way for full marketing authorisation in the next twoor three months. Approval in the key U.S. market remains someway off, since the drug will not be filed there until late 2014.

Bewertung: